During the past decade, Nantes University Hospital, Hôtel Dieu, Medical intensive care unit conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nantes University Hospital, Hôtel Dieu, Medical intensive care unit" are "Need for Intubation, No Severe Hypoxemia" (1 trials) and "Severe Obesity Design as BMI > 35kg/m2" (1 trials). Many other conditions were trialed in "Nantes University Hospital, Hôtel Dieu, Medical intensive care unit" in a lesser frequency.

Most popular intervention types in "Nantes University Hospital, Hôtel Dieu, Medical intensive care unit" are "Device" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Facial mask oxygenation in BIPAP ventilation" (1 trials), "High flow oxygen therapy by nasal cannula. Optiflow®" (1 trials), "OPTIFLOW/ AIRVO" (1 trials) and "STANDARD Face Mask" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nantes University Hospital, Hôtel Dieu, Medical intensive care unit" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Nantes University Hospital, Hôtel Dieu, Medical intensive care unit". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nantes University Hospital, Hôtel Dieu, Medical intensive care unit, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nantes University Hospital, Hôtel Dieu, Medical intensive care unit, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".